Skip to content
factget
Data FeedAlternative data

Biotech Catalysts

Trial readouts and drug decisions coming up for listed companies, with every date change kept.

01Overview

Every industry trial on ClinicalTrials.gov whose sponsor is a listed company: status, phase, enrollment and the primary completion date analysts watch, versioned at each registry update, so slipping readouts are visible. Plus FDA approvals and complete response letters (openFDA), FDA advisory committee meetings (Federal Register), EMA opinions and authorisations, and Health Canada notices of compliance.

Questions it answers

  • Which readouts are due next quarter, and have their dates slipped?
  • What did the FDA or EMA decide, and when?

Use cases

  • Catalyst calendars for biotech funds
  • Date-slip signals
  • Regulatory decision tracking across the US, EU and Canada
Coverage
64,193 values; 767 companies
History
Back to 1994
Update frequency
Every 15 minutes to weekly, by source
Key fields
Trial phase, status, primary completion date (actual or estimated), enrollment; approvals, CRLs, AdCom dates, EMA status
Point in time
Registry and regulator changes versioned at their posted dates
Sources
ClinicalTrials.gov API · openFDA (drugs@FDA, transparency data) · Federal Register (FDA advisory committees) · European Medicines Agency data file · Health Canada NOC API
Licence
US: public domain. EMA and Health Canada: delivered with the source credited
Delivery
Data API · MCP · Python SDK · Excel · S3/Snowflake files · App

Data as of 2 November 2026

02How point in time works

Each value carries the time it became public and the time Factget first saw it. Corrections and restatements are new versions; earlier versions stay queryable, so a backtest only sees what was known on each date. The source file behind every value is stored unaltered.

Talk to us

Build a datasetfrom your sources.

Tell us the sources and the fields you need. We’ll show you what factget can build, and keep current.